Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Lauren K. Wareham,Robert O. Baratta,Brian J. Del Buono,Eric Schlumpf,David J. Calkins

DOI: https://doi.org/10.1186/s13024-024-00704-0

2024-01-26

Molecular Neurodegeneration

Abstract:The extracellular matrix is a richly bioactive composition of substrates that provides biophysical stability, facilitates intercellular signaling, and both reflects and governs the physiological status of the local microenvironment. The matrix in the central nervous system (CNS) is far from simply an inert scaffold for mechanical support, instead conducting an active role in homeostasis and providing broad capacity for adaptation and remodeling in response to stress that otherwise would challenge equilibrium between neuronal, glial, and vascular elements. A major constituent is collagen, whose characteristic triple helical structure renders mechanical and biochemical stability to enable bidirectional crosstalk between matrix and resident cells. Multiple members of the collagen superfamily are critical to neuronal maturation and circuit formation, axon guidance, and synaptogenesis in the brain. In mature tissue, collagen interacts with other fibrous proteins and glycoproteins to sustain a three-dimensional medium through which complex networks of cells can communicate. While critical for matrix scaffolding, collagen in the CNS is also highly dynamic, with multiple binding sites for partnering matrix proteins, cell-surface receptors, and other ligands. These interactions are emerging as critical mediators of CNS disease and injury, particularly regarding changes in matrix stiffness, astrocyte recruitment and reactivity, and pro-inflammatory signaling in local microenvironments. Changes in the structure and/or deposition of collagen impact cellular signaling and tissue biomechanics in the brain, which in turn can alter cellular responses including antigenicity, angiogenesis, gliosis, and recruitment of immune-related cells. These factors, each involving matrix collagen, contribute to the limited capacity for regeneration of CNS tissue. Emerging therapeutics that attempt to rebuild the matrix using peptide fragments, including collagen-enriched scaffolds and mimetics, hold great potential to promote neural repair and regeneration. Recent evidence from our group and others indicates that repairing protease-degraded collagen helices with mimetic peptides helps restore CNS tissue and promote neuronal survival in a broad spectrum of degenerative conditions. Restoration likely involves bolstering matrix stiffness to reduce the potential for astrocyte reactivity and local inflammation as well as repairing inhibitory binding sites for immune-signaling ligands. Facilitating repair rather than endogenous replacement of collagen degraded by disease or injury may represent the next frontier in developing therapies based on protection, repair, and regeneration of neurons in the central nervous system.

neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the role of collagen in the central nervous system (CNS) and its potential therapeutic value in neurodegenerative diseases. Specifically, the article explores the following aspects: 1. **Biological Activity of Collagen**: Traditionally, collagen is considered mainly as a structural support protein, but this paper emphasizes the bioactive role of collagen in the CNS, especially its important role in maintaining tissue homeostasis, inter - cellular signal transduction, and adaptive remodeling in response to environmental stress. 2. **Relationship between Collagen and Neurodegenerative Diseases**: The article discusses the changes of collagen in various neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, and glaucoma). In particular, it focuses on how the changes in collagen structure and deposition affect cell signal transduction and tissue biomechanics, thereby driving disease progression and inflammatory states. 3. **Dynamic Characteristics of Collagen**: Collagen is not only structurally stable but also highly dynamic during its life cycle, forming a complex collagen interactome by binding with multiple molecular partners. These dynamic characteristics are particularly important during disease and aging processes. 4. **Therapeutic Potential**: The article proposes a treatment strategy for repairing the damaged collagen helix structure, especially using collagen mimetic peptides to restore CNS tissue and promote neuronal survival. These strategies may work by enhancing matrix stiffness, reducing astrocyte reactivity and local inflammation, and repairing the inhibitory binding sites of immune - signal ligands. In summary, this paper aims to deeply explore the multiple functions of collagen in the CNS and its potential therapeutic applications in neurodegenerative diseases.

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target

Targeting the neural extracellular matrix in neurological disorders

Collagen for neural tissue engineering: Materials, strategies, and challenges

Collagen I is a critical organizer of scarring and CNS regeneration failure

Glycosaminoglycans' for brain health: Harnessing glycosaminoglycan based biomaterials for treating central nervous system diseases and in-vitro modeling

“Teaching old dogs new tricks”: targeting neural extracellular matrix for normal and pathological aging-related cognitive decline

Co-administration of extracellular matrix-based biomaterials with neural stem cell transplantation for treatment of central nervous system injury

Targeting connexin 43 expression via scaffold mediated delivery of antisense oligodeoxynucleotide preserves neurons, enhances axonal extension, reduces astrocyte and microglial activation after spinal cord injury

Exploring the properties and potential of the neural extracellular matrix for next-generation regenerative therapies

A Collagen-Based Scaffold for Promoting Neural Plasticity in a Rat Model of Spinal Cord Injury

The Role of Extracellular Matrix in Human Neurodegenerative Diseases

Neurotrophic extracellular matrix proteins promote neuronal and iPSC astrocyte progenitor cell‐ and nano‐scale process extension for neural repair applications

A Modified Collagen Scaffold Facilitates Endogenous Neurogenesis for Acute Spinal Cord Injury Repair

Proteoglycans in the central nervous system: Plasticity, regeneration and their stimulation with chondroitinase ABC

Fibrous Viscoelastic Extracellular Matrix Assists Precise Neuronal Connectivity

Biomimetic Scaffolds for Spinal Cord Applications Exhibit Stiffness-Dependent Immunomodulatory and Neurotrophic Characteristics

Decellularised extracellular matrix-based biomaterials for repair and regeneration of central nervous system

Neural Tissue Homeostasis and Repair Is Regulated via CS and DS Proteoglycan Motifs

A glial perspective on the extracellular matrix and perineuronal net remodeling in the central nervous system

Biomimetic Dual‐Network Collagen Fibers with Porous and Mechanical Cues Reconstruct Neural Stem Cell Niche via AKT/YAP Mechanotransduction after Spinal Cord Injury

The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody.